196 related articles for article (PubMed ID: 35117597)
1. GLUT1/3/4 as novel biomarkers for the prognosis of human breast cancer.
Zeng K; Ju G; Wang H; Huang J
Transl Cancer Res; 2020 Apr; 9(4):2363-2377. PubMed ID: 35117597
[TBL] [Abstract][Full Text] [Related]
2. Glucose transporters GLUT1, GLUT3, and GLUT4 have different effects on osteoblast proliferation and metabolism.
Arponen M; Jalava N; Widjaja N; Ivaska KK
Front Physiol; 2022; 13():1035516. PubMed ID: 36523556
[TBL] [Abstract][Full Text] [Related]
3. The transcriptional STAT3 is a potential target, whereas transcriptional STAT5A/5B/6 are new biomarkers for prognosis in human breast carcinoma.
Wu HT; Liu J; Li GW; Shen JX; Huang YT
Oncotarget; 2017 May; 8(22):36279-36288. PubMed ID: 28422733
[TBL] [Abstract][Full Text] [Related]
4. Transcription factor c-Jun modulates GLUT1 in glycolysis and breast cancer metastasis.
Zhu P; Liu G; Wang X; Lu J; Zhou Y; Chen S; Gao Y; Wang C; Yu J; Sun Y; Zhou P
BMC Cancer; 2022 Dec; 22(1):1283. PubMed ID: 36476606
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatic analysis of the role of solute carrier-glutamine transporters in breast cancer.
Zhao X; Jin L; Liu Y; Liu Z; Liu Q
Ann Transl Med; 2022 Jul; 10(14):777. PubMed ID: 35965834
[TBL] [Abstract][Full Text] [Related]
6. Expression of glucose transporters in epithelial ovarian carcinoma: correlation with clinical characteristics and tumor angiogenesis.
Tsukioka M; Matsumoto Y; Noriyuki M; Yoshida C; Nobeyama H; Yoshida H; Yasui T; Sumi T; Honda K; Ishiko O
Oncol Rep; 2007 Aug; 18(2):361-7. PubMed ID: 17611657
[TBL] [Abstract][Full Text] [Related]
7. CMTM5/7 are biomarkers and prognostic factors in human breast carcinoma.
Wu J
Cancer Biomark; 2020; 29(1):89-99. PubMed ID: 32568178
[TBL] [Abstract][Full Text] [Related]
8. Expressions and prognostic values of the
Liu ZL; Bi XW; Liu PP; Lei DX; Wang Y; Li ZM; Jiang WQ; Xia Y
Cancer Manag Res; 2018; 10():3521-3532. PubMed ID: 30271201
[No Abstract] [Full Text] [Related]
9. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
10. Identification of Potential Therapeutic Targets Among CXC Chemokines in Breast Tumor Microenvironment Using Integrative Bioinformatics Analysis.
Chen E; Qin X; Peng K; Xu X; Li W; Cheng X; Tang C; Cui Y; Wang Z; Liu T
Cell Physiol Biochem; 2018; 45(5):1731-1746. PubMed ID: 29495008
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the Expression of
Chen C; Chen S; Pang L; Yan H; Luo M; Zhao Q; Lai J; Li H
Biomed Res Int; 2020; 2020():6412593. PubMed ID: 32104702
[TBL] [Abstract][Full Text] [Related]
12. An integrated bioinformatics analysis of potential therapeutic targets among matrix metalloproteinases in breast cancer.
Xia H; Yu W; Liu M; Li H; Pang W; Wang L; Zhang Y
Oncol Lett; 2019 Sep; 18(3):2985-2994. PubMed ID: 31452777
[TBL] [Abstract][Full Text] [Related]
13. Expression of facilitative glucose transporter isoforms in human brain tumors.
Nagamatsu S; Sawa H; Wakizaka A; Hoshino T
J Neurochem; 1993 Dec; 61(6):2048-53. PubMed ID: 8245960
[TBL] [Abstract][Full Text] [Related]
14. Expression analysis of facilitative glucose transporters (GLUTs) in human thyroid carcinoma cell lines and primary tumors.
Ciampi R; Vivaldi A; Romei C; Del Guerra A; Salvadori P; Cosci B; Pinchera A; Elisei R
Mol Cell Endocrinol; 2008 Sep; 291(1-2):57-62. PubMed ID: 18571834
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic value of glucose transporters in melanocytic lesions.
Ruby KN; Liu CL; Li Z; Felty CC; Wells WA; Yan S
Melanoma Res; 2019 Dec; 29(6):603-611. PubMed ID: 31135601
[TBL] [Abstract][Full Text] [Related]
16. Transcript levels of class I GLUTs within individual tissues and the direct relationship between GLUT1 expression and glucose metabolism in Atlantic cod (Gadus morhua).
Hall JR; Clow KA; Short CE; Driedzic WR
J Comp Physiol B; 2014 May; 184(4):483-96. PubMed ID: 24553996
[TBL] [Abstract][Full Text] [Related]
17. Expression patterns and the prognostic value of the SMYD family members in human breast carcinoma using integrative bioinformatics analysis.
Song J; Liu Y; Chen Q; Yang J; Jiang Z; Zhang H; Liu Z; Jin B
Oncol Lett; 2019 Apr; 17(4):3851-3861. PubMed ID: 30930987
[TBL] [Abstract][Full Text] [Related]
18. Systematic analysis of the expression and prognosis relevance of FBXO family reveals the significance of FBXO1 in human breast cancer.
Liu Y; Pan B; Qu W; Cao Y; Li J; Zhao H
Cancer Cell Int; 2021 Feb; 21(1):130. PubMed ID: 33622332
[TBL] [Abstract][Full Text] [Related]
19. Identification of Prognostic Biomarkers and Molecular Targets Among JAK Family in Breast Cancer.
Liu F; Wu H
J Inflamm Res; 2021; 14():97-114. PubMed ID: 33469338
[TBL] [Abstract][Full Text] [Related]
20. Altered GLUT1 and GLUT3 gene expression and subcellular redistribution of GLUT4: protein in muscle from patients with acanthosis nigricans and severe insulin resistance.
Stuart CA; Wen G; Williamson ME; Jiang J; Gilkison CR; Blackwell SJ; Nagamani M; Ferrando AA
Metabolism; 2001 Jul; 50(7):771-7. PubMed ID: 11436180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
